Kimberly Williamson

Kimberly Williamson is a seasoned professional in the pharmaceutical industry with extensive experience in business development and sales across various therapeutic areas. Currently serving as a Health Science Advisor at Otsuka Pharmaceutical Co., Ltd. since March 2023, Kimberly focuses on the launch of Rexulti for agitation associated with Alzheimer’s disease, emphasizing patient-centric care. Previously, as Senior Director of Business Development at ValueHealth LLC, Kimberly led entrepreneurial initiatives for ASC development and joint ventures. Experience as an Executive Therapeutic Specialist at Insmed Incorporated included educating on non-tuberculous Mycobacteria and launching a first-in-class nebulizer therapy. Kimberly's prior roles spanned key account management at Shire and territory management at Biogen, where complex clinical information was communicated to healthcare professionals. Notable achievements include the successful launches of several groundbreaking therapies and recognition for sales excellence. Kimberly holds a Bachelor of Fine Arts degree from Moore College of Art and Design.